XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   0 25,378,520      
Beginning balance at Dec. 31, 2021 $ 411,740 $ 0 $ 25 $ 505,482 $ (93,767) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 8,419     8,419    
Exercise of common stock options (in shares)     62,102      
Exercise of common stock options 399     399    
Issuance of common stock from vested restricted stock units and payment of employees' taxes (in shares)     2,466      
Issuance of common stock from vested restricted stock units and payment of employees’ taxes (56)     (56)    
Issuance of common stock under the employee stock purchase plan (in shares)     42,332      
Issuance of common stock under the employee stock purchase plan 1,457     1,457    
Net unrealized gain on marketable investment securities 0          
Net loss (24,623)       (24,623)  
Ending balance (in shares) at Mar. 31, 2022   0 25,485,420      
Ending balance at Mar. 31, 2022 397,336 $ 0 $ 25 515,701 (118,390) 0
Beginning balance (in shares) at Dec. 31, 2022   0 26,553,681      
Beginning balance at Dec. 31, 2022 399,150 $ 0 $ 27 560,409 (160,905) (381)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense $ 13,525     13,525    
Exercise of common stock options (in shares) 30,595   30,495      
Exercise of common stock options $ 95     95    
Issuance of common stock from vested restricted stock units and payment of employees' taxes (in shares)     24,835      
Issuance of common stock from vested restricted stock units and payment of employees’ taxes (314)     (314)    
Issuance of common stock under the employee stock purchase plan (in shares)     77,190      
Issuance of common stock under the employee stock purchase plan 1,652     1,652    
Net unrealized gain on marketable investment securities 245         245
Net loss (29,204)       (29,204)  
Ending balance (in shares) at Mar. 31, 2023   0 26,686,201      
Ending balance at Mar. 31, 2023 $ 385,149 $ 0 $ 27 $ 575,367 $ (190,109) $ (136)